INS and metabolic syndrome: This finding supports the previously mentioned idea that chemerin might be an early marker of insulin resistance, as it is capable of predicting the development of metabolic syndrome [16] or diabetes [7,79,87], detecting the alteration of insulin sensitivity [49,50,66], and discriminating subjects with subclinical diabetes [66,89].